Sort
50,496 grants matching “lung cancer”
The Antigen Targeting Core
$583,628Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$583,603Elad Ziv · University Of California, San Francisco · R01 · FY2022 · CA
Radiomics of NSCLC
$583,540Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2017 · CA
Etiologic Studies of Prostate Cancer
$583,507Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Thin Film Magnetic Sensors for Ultrathin Bronchoscope Navigation
$583,411Timothy H. Riehle · Koronis Biomedical Technologies Corporat · R44 · FY2008 · HL
Beta2 Adrenoceptor Structure and Mechanism of Activation
$583,346Brian K Kobilka · Stanford University · R01 · FY2012 · NS
Stroger Hospital of Cook County, Department of Surgery,*
$583,345Howard A Zaren · Hektoen Institute For Medical Research · U10 · FY2006 · CA
Metformin for chemoprevention of lung cancer in obese subjects at high risk
$583,338Saikrishna Yendamuri · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Maryland Prostate Cancer Case-Control Study
$583,310Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Managing Fatigue Using Virtual Reality for Post-Operative Lung Cancer Patients
$583,281Amy Jude Hoffman · University Of Nebraska Medical Center · R01 · FY2019 · CA
Functional assessment of genes and common genetic risk variants in ovarian cancer
$583,252Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2010 · CA
More than a Movement Disorder: Applying Palliative Care to Parkinson's Disease
$583,177Benzi M Kluger · University Of Colorado Denver · R01 · FY2016 · NR
Prognostic value of tumor hypoxia, as measured by 18F-FMISO Breath Hold PET/CT
$583,127Sadek Nehmeh · Sloan-Kettering Inst Can Research · U01 · FY2013 · CA
Targeting the ROR2/p-GSK3bS9 pathway to suppress metastasis in SMARCA4-deficient lung adenocarcinoma
$583,127David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Immune Therapy for Brain Metastasis
$583,091Lucia Beatrice Jilaveanu · Yale University · R01 · FY2023 · CA
Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules
$583,031Eric L Grogan · Vanderbilt University Medical Center · R01 · FY2025 · CA
Fabrication and Testing of a Novel PET insert for Simultaneous PET/MRI
$582,996Stuart S Berr · University Of Virginia · R01 · FY2020 · EB
KRAS G12C: Kinetic and Redox Characterization of Covalent Inhibition
$582,947Sharon L Campbell · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Role of IRF2 in cancer immune evasion and immunotherapy
$582,872Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · CA
Role of IRF2 in cancer immune evasion and immunotherapy
$582,872Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · CA
Biomarkers of NNK in prediction of lung cancer development in smokers
$582,849Jian-Min Yuan · University Of Minnesota · R01 · FY2010 · CA
Adenocarcinoma of the Lung: role of NNK susceptibility
$582,839Margaret R Spitz · University Of Tx Md Anderson Can Ctr · R01 · FY2008 · CA
Tumor and Metastasis Biology
$582,810Chand Khanna · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
THE EXTRACELLULAR MATRIX AS A COMPANION THERAPEUTIC TARGET IN METASTATIC LUNG CANCER
$582,748Yale Univ · · FY2016 · Department of Defense
Mechanism of lung cancer resistance to tyrosine kinase inhibitor and radiation treatments
$582,742Bing-Hua Jiang · University Of Iowa · R01 · FY2018 · CA